ANVS (STOCKS)
Annovis Bio, Inc.
$2.375000
-0.025000 (-1.04%)
Prev close: $2.400000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Maria-Luisa Maccecchini
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $63.08M
- Employees
- 6
- P/E (TTM)
- -1.60
- P/B (TTM)
- 3.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.84M |
| Operating Expenses | $26.72M |
| Research and Development | $21.46M |
| Other Operating Expenses | $5.26M |
| Operating Income/Loss | -$26.72M |
| Income/Loss From Continuing Operations After Tax | -$24.88M |
| Income/Loss From Continuing Operations Before Tax | -$24.88M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$24.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.39 |
| Diluted Earnings Per Share | -$1.43 |
| Basic Average Shares | 57,390,282 |
| Diluted Average Shares | 57,376,682 |
| Assets | $17.19M |
| Current Assets | $17.19M |
| Noncurrent Assets | $0.00 |
| Liabilities | $4.03M |
| Current Liabilities | $3.73M |
| Accounts Payable | $2.11M |
| Wages | $706.65K |
| Other Current Liabilities | $915.12K |
| Noncurrent Liabilities | $299.00K |
| Equity | $13.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.16M |
| Liabilities And Equity | $17.19M |
| Net Cash Flow From Operating Activities | -$24.98M |
| Net Cash Flow From Operating Activities, Continuing | -$24.98M |
| Net Cash Flow From Investing Activities | -$2.65M |
| Net Cash Flow From Investing Activities, Continuing | -$2.65M |
| Net Cash Flow From Financing Activities | $27.63M |
| Net Cash Flow From Financing Activities, Continuing | $27.63M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$24.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.88M |
| Other Comprehensive Income/Loss | $0.00 |